Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    5.00 (0.22%)
Bid:
2,295.00
Ask:
2,310.00
Spread: 15.00 (0.654%)
Market Cap: £3.14b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 Jun 2024 07:00

RNS Number : 5730S
RIT Capital Partners PLC
17 June 2024
Β 

RIT Capital Partners plc (LEI: P31Q1NLTW35JJGHA4667)

Β 

17 June 2024

Β 

31 May 2024 Net Asset Value

Β 

RIT Capital Partners plc announces that its unaudited diluted Net Asset Value ("NAV") as at 31 May 2024, calculated with debt at fair value, was 2,540p per Β£1 ordinary share (30 April 2024: 2,511p).

Β 

May 2024 Commentary

Β 

Global equities rebounded in May with US Federal Reserve continuing to signal interest rate cuts and economic data that supported the disinflation narrative, resulting in the S&P 500 rising by +5%. European shares also showed recovery, with STOXX 600 returning +3.5% reflecting the market's anticipation of a rate cut by the ECB. On the other hand, despite relatively robust economic data, China saw a -0.5% decline across the Shenzhen 300 as ongoing real estate debt pressures continue to weigh on investor sentiment. The US dollar gave back some of its year-to-date strength and fell -2% against sterling in the month. The price of gold continued to rise, reaching an all-time high of $2,450 in the same period.

Β 

Portfolio highlights

Β 

Our portfolio posted positive performance in May, with a total return of 1.1% despite a partial offsetting of returns caused by our exposure to the US dollar. This increase in value was driven by gains across all three of our strategic investment pillars.

Β 

Β·

An increase in the value of our Quoted Equities book was driven by healthy returns from our external managers and strong performance from our directly held small and mid-cap equities, an area where we currently see opportunity. With some expected offset on our portfolio hedges, the book saw a positive outcome overall.Β 

Β 

Β·

Private Investments were a solid contributor during the month, driven by gains from our private funds which saw an uplift in Q1 valuations. As of 31 May, 97% of our private funds were held at 31 March reported valuations and 2% were held at 31 December valuations. All private direct holdings are valued at 31 December, in line with our half-yearly valuation process for these holdings.

Β 

Β·

Uncorrelated Strategies also contributed positively to our total return for the month, driven largely by credit holdings performing strongly.

Β 

Β·

The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. For the year to 31 May, the Company has repurchased approximately 1.5 million shares on behalf of shareholders.

Β 

Β 

Β 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

Β 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

Β 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

Β 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Sofie Brewis

T:Β 020 7404 5959

E:Β RIT@BrunswickGroup.comΒ 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVEZLFFZQLZBBK
Date   Source Headline
29th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSTransaction in Own Shares
20th Sep 20227:00 amRNSTransaction in Own Shares
16th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20227:00 amRNSNet Asset Value(s)
7th Sep 20227:00 amRNSTransaction in Own Shares
6th Sep 20227:00 amRNSTransaction in Own Shares
17th Aug 20225:29 pmRNSDirector/PDMR Shareholding
12th Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20229:45 amRNSBoard Appointments
2nd Aug 20227:00 amRNSHalf-year Report
20th Jul 20227:00 amRNSNet Asset Value(s)
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSNet Asset Value(s)
17th May 20227:00 amRNSNet Asset Value(s)
4th May 20224:51 pmRNSResult of AGM
27th Apr 20222:24 pmRNSDirector/PDMR Shareholding
26th Apr 20224:40 pmRNSBoard Appointment
19th Apr 20227:00 amRNSNet Asset Value(s)
14th Mar 20227:00 amRNSNet Asset Value(s)
1st Mar 20227:00 amRNSAnnual Financial Report
23rd Feb 20224:18 pmRNSHolding(s) in Company
22nd Feb 20222:45 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSNet Asset Value(s)
15th Feb 20224:26 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSNet Asset Value(s)
15th Dec 20217:00 amRNSNet Asset Value(s)
3rd Dec 20217:00 amRNSDirector Declaration
23rd Nov 20215:22 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSNet Asset Value(s)
4th Nov 20214:57 pmRNSBoard Announcements
15th Oct 20217:00 amRNSNet Asset Value(s)
15th Sep 20217:00 amRNSNet Asset Value(s)
16th Aug 20217:00 amRNSNet Asset Value(s)
2nd Aug 20217:00 amRNSHalf-year Report
20th Jul 20217:00 amRNSNet Asset Value(s)
28th Jun 20216:17 pmRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSTransaction in Own Shares
22nd Jun 20217:00 amRNSTransaction in Own Shares
15th Jun 20217:00 amRNSNet Asset Value(s)
21st May 20215:15 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSNet Asset Value(s)
22nd Apr 20215:52 pmRNSResult of AGM
19th Apr 20217:00 amRNSNet Asset Value(s)
13th Apr 20214:17 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSDirector/PDMR Shareholding
24th Mar 20216:17 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.